| |
| | SNOTE | A | Ancillary studies to evaluate pathogenesis, genetic factors, proteomics, metabolomics, lipidomics, imaging ... |
 | | Ancillary studies to evaluate pathogenesis, genetic factors, proteomics, metabolomics, lipidomics, imaging studies and determinates of progression and severity of NASH, NAFLD or crytogenic cirrhosis. |
 | | Ancillary studies to evaluate the natural history, pathogenesis, genetic factors, proteomics, metabolomics, lipidomics, imaging studies, and determinants of progression and severity of nonalcoholic fatty liver disease present a variety of opportunities for CRADAs. |
 | | (4) Develop serum/plasma proteomic, metabolomic, and lipidomic expression arrays that are diagnostic of fatty liver disease or NASH or cryptogenic cirrhosis and that would provide staging and grading of the degree of cell injury, steatosis and fibrosis in the liver as well as insights into the pathogenesis of this disease. |
| www.fbodaily.com /archive/2005/04-April/01-Apr-2005/FBO-00778467.htm (1448 words) |
|